晚期心力衰竭的息护理:系统审查和元分析
Shuhui Yang1,2, Yan Jiang3,4, Cong Wang2,5
1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
BMJ supportive & palliative care
|February 27, 2026
概括
息治疗显著改善生活质量,减少焦虑和抑郁,并降低晚期心力衰竭患者的再入院率. 虽然它增强了心脏功能,但它没有影响死亡率.
科学领域:
- 心脏病学 心脏病学
- 抚慰性医学是一种缓解性医学.
- 生活质量研究 研究 生命质量研究
背景情况:
- 晚期心力衰竭对患者福祉和医疗保健系统构成重大挑战.
- 息治疗旨在改善患有严重疾病的患者的生活质量.
- 晚期心力衰竭患者的息护理的具体好处需要系统评估.
研究的目的:
- 系统地评估息治疗对生活质量,焦虑,抑郁,心脏功能,再入院率和晚期心力衰竭死亡率的影响.
- 为在高级心力衰竭管理中实施息治疗提供基于证据的支持.
主要方法:
- 进行了随机对照试验 (RCT) 的系统审查和元分析.
- 在多个数据库 (CNKI,WANFANG DATA,CQVIP,SinoMed,CINAHL,Medline,PubMed,Web of Science,Embase) 进行了搜索,截至2025年7月17日.
- 数据提取和质量评估遵循了柯克兰手册,并使用RevMan 5.3.3进行了元分析.
主要成果:
- 包括20个涉及2165名患者的RCT.
- 息治疗显著改善了生活质量 (SMD=1.12),减少了焦虑 (SMD=-1.27) 和抑郁 (SMD=-1.33).
- 心脏功能得到改善 (MD=4.41) 和重新入院率降低 (RR=0.70),但死亡率没有显著影响 (RR=1.29).
结论:
- 息护理为患有晚期心力衰竭的患者提供了显著的好处,提高了生活质量并减轻了心理痛苦.
- 它对心脏功能产生积极影响,并减少重入院,支持其融入临床实践.
- 建议进一步进行高质量的大样本研究,以探索息治疗的全部影响,特别是对死亡率的影响.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
9.1K
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
7.1K
相关概念视频
01:30Heart Failure VII: Nursing Interventions
599
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
599
01:22Heart Failure VI: Adjunct Therapies
474
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
474
01:30Heart Failure V: Medical Management
428
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
428
01:30Heart Failure IV: Classification and Diagnostic Evaluation
486
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
486
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
01:17Pathophysiology of Heart Failure
4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K